Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Hepatocellular 4Adenocarcinoma of Lung 2Recurrence 1Non-Small Cell Lung Cancer Without Mutation in Epidermal Growth Factor Receptor (Disorder) 1Neoplasms 1Liver Neoplasms 1Glioblastoma 1Esophageal Squamous Cell Carcinoma 1Endometrial Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Advanced Solid Tumor 1

Interventions

tislelizumab 2Early Intervention, Educational 2Carboplatin 2Anterior Temporal Lobectomy 2Vitamin B 12 1Taxes 1Standard of Care 1Smoking Devices 1Radiotherapy, Image-Guided 1Radiotherapy, Conformal 1Radiotherapy 1Radiosurgery 1Radiofrequency Ablation 1Practice Guidelines as Topic 1Platinum 1Pemetrexed 1Paclitaxel 1Morphine 1Methods 1Mastectomy, Segmental 1Magnetic Resonance Spectroscopy 1Lymph Node Excision 1Gefitinib 1Folic Acid 1Fluorodeoxyglucose F18 1Exercise 1Diet, Ketogenic 1Bupivacaine 1Anti-Inflammatory Agents, Non-Steroidal 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Adenocarcinoma of Lung × tislelizumab × Clear all
NCT06056115 2023-09-28

Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic

Hebei Medical University Fourth Hospital

Phase NA Recruiting
20 enrolled
Thoracic

Adenocarcinoma of Lung

NCT05527808 2023-06-08

A Single-arm Exploratory Study of Neoadjuvant Therapy

Guangzhou Institute of Respiratory Disease

Phase NA Unknown
28 enrolled
Thoracic

Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡